A phase III trial of vinflunine + capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with or resistant to an anthracycline and who are taxane resistant
A phase III trial of vinflunine + capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with or resistant to an anthracycline and who are taxane resistant
Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer
A phase III trial of vinflunine + capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with or resistant to an anthracycline and who are taxane resistant
Status
Status :
Completed
Type of study
Phase III
Min. Age
18
Years old
Max. Age
85
Years old
Gender
Female
Therapeutic area :
Oncology
Disease :
Breast cancer
Study medication :
Vinflunine (Javlor®)
Phase :
Phase III
Start Date :
May 06, 2009
End date :
September 18, 2015
Study ID :
L00070 IN 305 B0
EudraCT/CTIS number :
2008-004171-21
CT.gov Number :
NCT01095003
Send by email